JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Congenital nevocytic nevi: follow-up of a Swedish birth register sample regarding etiologic factors, discomfort, and removal rate.

Congenital nevi both small and large are frequently removed. We attempted to study the removal rate and etiologic aspects of congenital nevi as well as their psychosocial effects through the use of a quality test. A questionnaire sent to a sample population of individuals with congenital nevocytic nevi (n=192) collected from the Swedish Medical Birth Register (SMBR) was used as a test of the register's quality and for collecting information on rate of removal and etiologic factors. The quality test indicated that only 85.3% of the nevi listed in the SMBR were true congenital nevocytic nevi. Of all true congenital nevocytic nevi reported in the questionnaire, 39.8% had been removed and none of the rest had developed malignant melanoma. The median time for follow-up was 14 years. The median age at removal of the nevi was 9.7 years. Eight percent of respondents believed that the skin lesion caused taunting and changed their social activities. No infection or illness during pregnancy was specifically related to the development of congenital nevi. In conclusion, the larger the nevi, the more frequently and earlier they are excised. With an excision rate of 40% of congenital nevocytic nevi, we found no malignant melanoma.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app